Additional Management Team Announcement with Promotion of Robert Silverman January 19, 2011, Lexington, MA -- Concert Pharmaceuticals, Inc. announced today the appointment of James E. Shipley, M.D., …
News
Precision Therapeutics Announces New Study on Multi-Gene Predictors at 2010 San Antonio Breast Cancer Symposium
PITTSBURGH, Jan. 17, 2011 /PRNewswire/ -- In a new study in which Precision Therapeutics' Multi-Gene Predictors (MGPs) were independently validated by investigators at US Oncology and MD Anderson, …
New Patents Continue to issue for Concert Pharmaceuticals Deuterium Chemistry Intellectual Property
January 13, 2011 Lexington, MA –- Concert Pharmaceuticals, Inc. announced the issuance of several new patents relating to specific compounds derived from its DCE Platform™ (Deuterated Chemical Entity …
Anchor Therapeutics Achieves Milestone in GPCR Collaboration
-- Significant Progress Over First Four Months of Joint Research -- Cambridge, MA - January 7, 2011 - Anchor Therapeutics today announced that it has successfully completed the first stage of its …
EUSA Pharma Announces Priority Review Status for ERWINAZE® BLA
Langhorne, PA and Oxford, UK – 5 January 2011 EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its …